A Further Spotlight on OpRegen – A RPE Transplant for Dry AMD with GA
Time: 11:00 am
day: Track 2 Day 2 AM
Details:
- Reiterative how a transplant of RPE cells can be both robust and endured by patients with dry-AMD
- Understand further the benefits of OpRegen RPE cells in specific patients with dry-AMD, as well as primary indication of RPE-photoreceptor complex regeneration (GA reduction)
- Evaluate how RPE cell suspensions can be reasonably scaled to marketable quantities
